ACTRN12609000339257进行中（未招募）未知
Colorectal adenocarcinoma patients followed through their chemotherapy for assessing oral mucositis manifestations.
Sao Paulo University0 个研究点目标入组 25 人开始时间: 2009年5月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients surgically treated of a colorectal adenocarcinoma and elected to receive chemotherapy composed of fluorouracil and folinic acid according to a bolus delivering regimen
排除标准
- •Patients that do not match the inclusion criteria will not be eligible for the study. Adittionally patients that suffer any modification in their chemotherapy protocol during the course of the trial will be also excluded.
研究者
相似试验
已完成
不适用
Colomid: Midkine as a predictive marker in colorectal cancerACTRN12613000111774Calvary Mater Newcastle Hospital33
已完成
不适用
Vitamin C for Colorectal Cancer: A clinical window study to assess high dose vitamin C administration in colorectal cancer patientsCancer - Bowel - Back passage (rectum) or large bowel (colon)Colorectal cancerACTRN12615001277538Prof Margreet Vissers12
进行中（未招募）
不适用
Colorectal cancer cohort study (COLO-COHORT)Colorectal neoplasia, colorectal cancerColorectal neoplasiaCancerISRCTN17473023South Tyneside and Sunderland NHS Foundation Trust15,000
进行中（未招募）
1 期
A study for people with advanced colorectal cancer who have been treated with a specific chemotherapy regimen (Bevacizumab, Oxaliplatin, and a Fluoropyrimidine) which was ineffective in stopping the spread of the colorectal cancer. Study participants will receive a different chemotherapy regimen (Irinotecan, Folinic Acid, and 5-Fluorouracil) and be randomly and unknowingly assigned to also receive the study drug (ramucirimab) or a non-active compound (placebo).Metastatic Colorectal CancerMedDRA version: 17.0Level: LLTClassification code 10010036Term: Colorectal carcinomaSystem Organ Class: 100000004864EUCTR2010-021037-32-DEEli Lilly and Company Limited, Indianapolis1,050
进行中（未招募）
不适用
Treatment Monitoring of Advanced Colorectal cancer with 18F-FDG PET/CTEUCTR2008-001499-55-FITurku PET Centre140